Compare NRSN & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRSN | HUIZ |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 35.2M |
| IPO Year | 2021 | 2020 |
| Metric | NRSN | HUIZ |
|---|---|---|
| Price | $0.88 | $3.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | $2.30 |
| AVG Volume (30 Days) | ★ 468.0K | 4.3K |
| Earning Date | 04-06-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $186,519,166.00 |
| Revenue This Year | N/A | $22.67 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $14.02 |
| Revenue Growth | N/A | ★ 19.12 |
| 52 Week Low | $0.81 | $1.50 |
| 52 Week High | $2.60 | $5.24 |
| Indicator | NRSN | HUIZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.97 | 61.38 |
| Support Level | $0.86 | $3.32 |
| Resistance Level | $1.24 | $3.79 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 6.58 | 86.04 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.